Article Text
Abstract
Preimplantation tissue typing has been proposed as a method for creating a tissue matched child that can serve as a haematopoietic stem cell donor to save its sick sibling in need of a stem cell transplant. Despite recent promising results, many people have expressed their disapproval of this method. This paper addresses the main concerns of these critics: the risk of preimplantation genetic diagnosis (PGD) for the child to be born; the intention to have a donor child; the limits that should be placed on what may be done to the donor child, and whether the intended recipient can be someone other than a sibling. The author will show that these concerns do not constitute a sufficient ground to forbid people to use this technique to save not only a sibling, but also any other loved one’s life. Finally, the author briefly deals with two alternative scenarios: the creation of a human leukocyte antigen (HLA) matched child as an insurance policy, and the banking of HLA matched embryos.
- DBA, diamond blackfan anaemia
- HLA, human leukocyte antigen, HSC, haematopoietic stem cell
- PGD, preimplantation genetic diagnosis
- histocompatibility testing
- preimplantation diagnosis
- haematopoietic stem cells
- tissue donors
- embryo
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do “saviour siblings” have in paediatric transplantation?
- My approach to the immunogenetics of haematopoietic stem cell transplant matching
- The inference from a single case: moral versus scientific inferences in implementing new biotechnologies
- Britain’s new preimplantation tissue typing policy: an ethical defence
- Extending preimplantation genetic diagnosis: medical and non-medical uses
- Ethics briefings
- Ethics of using preimplantation genetic diagnosis to select a stem cell donor for an existing person
- Should selecting saviour siblings be banned?
- Status of umbilical cord blood transplantation in the year 2001
- False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia